Saba Capital Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-249,300
Closed -$3.97M 98
2018
Q1
$3.97M Buy
249,300
+144,541
+138% +$2.69M 0.22% 57
2017
Q4
$2.18M Sell
104,759
-1,244,300
-92% -$19.7M 0.17% 79
2017
Q3
$19.3M Sell
1,349,059
-273,629
-17% -$4.14M 1.96% 13
2017
Q2
$28.1M Sell
1,622,688
-693,212
-30% -$8.31M 2.55% 13
2017
Q1
$25.5M Buy
2,315,900
+1,319,311
+132% +$18.1M 2.28% 15
2016
Q4
$14.5M Buy
996,589
+549,238
+123% +$10.1M 1.47% 24
2016
Q3
$11M Buy
447,351
+20,970
+5% +$543K 1.07% 31
2016
Q2
$8.59M Buy
426,381
+303,550
+247% +$8.59M 0.77% 37
2016
Q1
$3.23M Buy
+122,831
New +$9.08M 0.31% 57

Other funds holding BHC

Saba Capital Management's BHC Position: Q2 2018 in Review

Saba Capital Management sold out of Bausch Health (BHC) in Q2 2018, closing a stake of 249,300 shares — an estimated $3.97M sold.

Saba Capital Management first reported a position in BHC in Q1 2016 and held it in 9 quarters. The position peaked at $28.1M in Q2 2017. 311 funds tracked by Wall St. Rank hold BHC as of Q2 2018.

  • Saba Capital Management reported no remaining Bausch Health position as of Q2 2018 after selling out during the quarter.
  • Saba Capital Management sold 249,300 Bausch Health shares in Q2 2018, an estimated $3.97M.
  • Saba Capital Management first reported a position in Bausch Health in Q1 2016 and held it in 9 quarters.
  • Saba Capital Management's Bausch Health position peaked at $28.1M in Q2 2017.
  • 311 funds tracked by Wall St. Rank held Bausch Health as of Q2 2018.

Based on Saba Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.